Successfully navigating the stages of a biotech companies requires an understanding of the risks and rewards. Biotech is a high-growth, high-risk industry that requires significant capital at each stage for R&D, human capital, regulatory adherence, reimbursement planning, and intellectual property protection. Product development is complex and needs to be supported by a business model that optimizes financing, market, and operational strategies. Our experienced panel of experts will give you insight into the lifecycle of a biotech company, so that you will be a knowledgeable and trusted advisor.

SPEAKERS:

Steven S. Brooks, MD, MBA, FACC
Sage Growth Partners (SGP)

George Davis
Gemstone Biotherapeutics LLC

Abba Poliakoff
Gordon Feinblatt

REGISTER
FEE:  Premier Member : $0, Member Plus : $30, Member : $30, Non Member : $40

Contact: Angelique Waldron or call: 240-243-4041